These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5231391)

  • 41. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis.
    Hathaway BA; Guo ZR; Hansch C; Delcamp TJ; Susten SS; Freisheim JH
    J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species.
    Baker BR; Jordaan JH
    J Pharm Sci; 1967 May; 56(5):660-1. PubMed ID: 5340324
    [No Abstract]   [Full Text] [Related]  

  • 43. Differential binding to the hydrophobic bonding region of T2 phage induced, Escherichia coli B, and pigeon liver dihydrofolic reductases.
    Baker BR
    J Med Chem; 1967 Sep; 10(5):912-7. PubMed ID: 4860445
    [No Abstract]   [Full Text] [Related]  

  • 44. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
    Zhou X; Lin K; Ma X; Chui WK; Zhou W
    Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quinazolines. II. 2-Guanidino-4,6,7-trimethylquinazoline as a by-product in the three-component synthesis of 4,6-diamino-2,2-dimethyl-1-(3,4-xylyl)-1,2-dihydro-s-triazine-1,2.
    Rosowsky A; Protopapa HK; Modest EJ
    J Org Chem; 1965 Jan; 30(1):285-8. PubMed ID: 5871041
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazines.
    Hansch C; Dietrich SW; Fukunaga JY
    J Med Chem; 1981 May; 24(5):544-9. PubMed ID: 7241512
    [No Abstract]   [Full Text] [Related]  

  • 47. 10-Formyl-dihydrofolic acid is bioactive in human leukemia cells.
    Baggott JE; Johanning GL
    J Nutr; 1999 Jul; 129(7):1315-8. PubMed ID: 10395592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative structure-activity relationships of the inhibition of Pneumocystis carinii dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(X-phenyl)-s-triazines.
    Marlowe CK; Selassie CD; Santi DV
    J Med Chem; 1995 Mar; 38(6):967-72. PubMed ID: 7699713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA).
    Ma X; Xiang G; Yap CW; Chui WK
    Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 52. Accumulation of (3',5'-3H2)folic acid by human blood platelets. Effect of dihydrofolic acid reductase inhibitors.
    Gaut ZN; Solomon HM; Baugh CM
    Biochim Biophys Acta; 1970 Jul; 215(1):194-7. PubMed ID: 5494513
    [No Abstract]   [Full Text] [Related]  

  • 53. Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor.
    Baker BR; Santi DV
    J Pharm Sci; 1965 Sep; 54(9):1252-7. PubMed ID: 5881214
    [No Abstract]   [Full Text] [Related]  

  • 54. Dihydrofolate reductase and aminopterin resistance in Pneumococcus.
    Benedict SH; Gray TC
    Mol Gen Genet; 1973 Mar; 122(1):23-36. PubMed ID: 4144732
    [No Abstract]   [Full Text] [Related]  

  • 55. Analogs of tetrahydrofolic acid XX. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol on inhibition of dihydrofolic reductase and thymidylate synthetase II.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Aug; 54(8):1187-90. PubMed ID: 5882225
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of 4,6-diamino-symm-triazines on nucleic acids of liver and kidney in rats].
    Kuznetsova LI; Okunev VN
    Ukr Biokhim Zh; 1970; 42(5):617-20. PubMed ID: 5511478
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of folate antagonists on dihydrofolate reductase activity demonstrated cytochemically.
    Tzortzatou F; Hayhoe FG
    Br J Haematol; 1974 Oct; 28(2):209-16. PubMed ID: 4433479
    [No Abstract]   [Full Text] [Related]  

  • 58. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines.
    Guo ZR; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors.
    Basak SC; Mills D
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):215-29. PubMed ID: 20544548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain.
    Rosowsky A; Forsch RA; Bader H; Freisheim JH
    J Med Chem; 1991 Apr; 34(4):1447-54. PubMed ID: 2016722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.